![Richard Maurice Walmsley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Maurice Walmsley
Oprichter bij Gentronix Ltd.
Actieve functies van Richard Maurice Walmsley
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Gentronix Ltd.
![]() Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | 01-01-1999 | - |
Oprichter | 22-03-2010 | - | |
University of Manchester Institute of Science & Technology | Corporate Officer/Principal | - | - |
Loopbaan van Richard Maurice Walmsley
Opleiding van Richard Maurice Walmsley
University of Kent | Doctorate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 4 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Gentronix Ltd.
![]() Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Health Technology |